MedPath

Evalutation of the multidimensional assessement-tool RoBa (Ressource oriented analysis of demand) to gather the activity, nutrition and quality of life status of cancer patients

Recruiting
Conditions
colorectal cancer, pancreatic cancerMalnutrition, physical inactivity, chronic inflammation
Registration Number
DRKS00026620
Lead Sponsor
MU Klinikum, Medizinische Klinik und Poliklinik III
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

primary cancer diganosis (colorectal cancer, pancreatic cancer) before or at the beginning of cancer treatment
life expactancy = 12 months
ECOG = 2
Written and valid informed consent

Exclusion Criteria

contraindication against the spiroergometry:
- severe coronary insufficiency (NYHA III-IV)
- therapy refractory high blood pressure III-IV°
- respiratory insufficiency, COPD >III°
- therapy refractory thrombocytopenia < 10.000/µl
- uncontrolled hemorrhagic diathesis
- instable coronary syndrom
- instable cardiac arrhythmias
- unconsontrolled cerebric epilepsy

contraindication against bioimpedance analysis:
- implanted pacemaker or defibrillator
- Non-detachable, active protheses with electric control
pregnancy
Missing informed consent

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
clinical feasibility of the RoBa-assessment as a whole with it´s twelve single tests
Secondary Outcome Measures
NameTimeMethod
- comparison of the validity and results of the single assessments with the results in the aggregated score.<br>- Analysis of subgroups regarding tumor entity, tumor stage, ECOG, gender
© Copyright 2025. All Rights Reserved by MedPath